Who are Isoniazid with Ethambutol's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/isoniazid-with-ethambutol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Isoniazid with Ethambutol — Competitive Intelligence Brief

Isoniazid with Ethambutol (Isoniazid with Ethambutol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antituberculous agents. Area: Infectious Disease.

phase 3 Antituberculous agents InhA (isoniazid); arabinosyl transferases (ethambutol) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Isoniazid with Ethambutol (Isoniazid with Ethambutol) — Tuberculosis Research Centre, India. Isoniazid and ethambutol are bactericidal and bacteriostatic agents that inhibit mycobacterial cell wall and metabolic synthesis, respectively, to treat tuberculosis infection.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Isoniazid with Ethambutol TARGET	Isoniazid with Ethambutol	Tuberculosis Research Centre, India	phase 3	Antituberculous agents	InhA (isoniazid); arabinosyl transferases (ethambutol)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antituberculous agents class)

Tuberculosis Research Centre, India · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Isoniazid with Ethambutol — Competitive Intelligence Brief. https://druglandscape.com/ci/isoniazid-with-ethambutol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab